VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 224 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $760 | +68.5% | 81,094 | +341.4% | 0.01% | +75.0% |
Q2 2023 | $451 | -50.2% | 18,374 | -52.8% | 0.00% | -42.9% |
Q1 2023 | $905 | +48.1% | 38,892 | +61.2% | 0.01% | -22.2% |
Q4 2022 | $611 | -99.9% | 24,125 | -38.7% | 0.01% | -10.0% |
Q3 2022 | $759,000 | -33.7% | 39,368 | -12.5% | 0.01% | -28.6% |
Q2 2022 | $1,145,000 | -22.3% | 44,968 | -21.6% | 0.01% | -26.3% |
Q1 2022 | $1,474,000 | +53.1% | 57,327 | +205.1% | 0.02% | +35.7% |
Q1 2021 | $963,000 | – | 18,790 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 1,559,142 | $14,609,161 | 17.42% |
SB INVESTMENT ADVISERS (UK) LTD | 16,684,041 | $156,329,464 | 1.29% |
Octagon Capital Advisors LP | 325,050 | $3,045,719 | 0.47% |
SECTOR GAMMA AS | 148,538 | $1,391,801 | 0.36% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 1,345,635 | $12,608,600 | 0.31% |
ALGERT GLOBAL LLC | 449,685 | $4,214 | 0.20% |
Quantamental Technologies LLC | 18,519 | $173,523 | 0.16% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 47,000 | $439,920 | 0.15% |
DUALITY ADVISERS, LP | 123,871 | $1,160,671 | 0.14% |
Empowered Funds, LLC | 385,135 | $3,608,715 | 0.11% |